Specifically, we have demonstrated that LBT exerts significant reductions in TNF-α, IL-6, and IL-1β levels while mitigating LPS-induced sepsis through the inhibition of genes associated with bacterial infection, cellular response to lipopolysaccharide, and cytokine-cytokine receptor interaction. The gene discussed is TNF; the disease is Sepsis.